FT
GBT

Fiduciary Trust’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Fiduciary Trust’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,550
Closed -$369K – 647
2022
Q2 		$369K Hold
11,550
– – 0.01% 502
2022
Q1 		$400K Hold
11,550
– – 0.01% 508
2021
Q4 		$338K Hold
11,550
– – 0.01% 538
2021
Q3 		$294K Hold
11,550
– – 0.01% 567
2021
Q2 		$404K Hold
11,550
– – 0.01% 498
2021
Q1 		$471K Hold
11,550
– – 0.01% 461
2020
Q4 		$500K Hold
11,550
– – 0.01% 431
2020
Q3 		$637K Hold
11,550
– – 0.02% 355
2020
Q2 		$729K Hold
11,550
– – 0.02% 326
2020
Q1 		$590K Sell
11,550
-3
-0% -$201 0.02% 327
2019
Q4 		$918K Hold
11,553
– – 0.02% 290
2019
Q3 		$561K Buy
11,553
+3
+0% +$156 0.01% 353
2019
Q2 		$608K Hold
11,550
– – 0.02% 325
2019
Q1 		$611K Sell
11,550
-10,000
-46% -$491K 0.02% 318
2018
Q4 		$885K Hold
21,550
– – 0.03% 247
2018
Q3 		$819K Hold
21,550
– – 0.02% 281
2018
Q2 		$974K Hold
21,550
– – 0.03% 252
2018
Q1 		$1.04M Sell
21,550
-6,054
-22% -$338K 0.03% 247
2017
Q4 		$1.09M Buy
27,604
+4,024
+17% +$150K 0.03% 242
2017
Q3 		$732K Buy
23,580
+1,701
+8% +$47.8K 0.02% 284
2017
Q2 		$598K Buy
21,879
+7,970
+57% +$237K 0.02% 316
2017
Q1 		$513K Buy
+13,909
New +$350K 0.02% 326

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fiduciary Trust's GBT Position: Q3 2022 in Review

Fiduciary Trust sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 11,550 shares — an estimated $369K sold.

Fiduciary Trust first reported a position in GBT in Q1 2017 and held it in 22 quarters. The position peaked at $1.09M in Q4 2017. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Fiduciary Trust reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Fiduciary Trust sold 11,550 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $369K.
  • Fiduciary Trust first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 22 quarters.
  • Fiduciary Trust's Global Blood Therapeutics, Inc. position peaked at $1.09M in Q4 2017.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Fiduciary Trust's 13F filing for Q3 2022, filed 14 Nov 2022.